| BT 2018_Immunohaematology |
| Editorial Office |
|
| Selective organ ischaemia/reperfusion identifies liver as the key driver of the post-injury plasma metabolome derangements |
| Nathan Clendenen, Geoffrey R. Nunns, Ernest E. Moore, Eduardo Gonzalez, Michael Chapman, Julie A. Reisz, Erik Peltz, Miguel Fragoso, Travis Nemkov, Matthew J. Wither, Angela Sauaia, Christopher C. Silliman, Kirk Hansen, Anirban Banerjee, Angelo D'Alessandro, Hunter B. Moore |
|
| Multiple electrode aggregometry and thromboelastography in thrombocytopenic patients with haematological malignancies |
| Elin N. Opheim, Torunn O. Apelseth, Simon J. Stanworth, Geir E. Eide, Tor Hervig |
|
| BT 2018_Blood components and regenerative medicine |
| Editorial Office |
|
| BT 2018_Blood donation and donor infectious disease testing |
| Editorial Office |
|
| BT 2018_Patient Blood Management |
| Editorial Office |
|
| Fibrinogen measurement in liver disease: validation of the functional fibrinogen thromboelastography assay and a novel mathematical predictive model |
| Kirsty Rizzo, Kevin Vella, Daniel Zammit, Peter Gatt, Charlie Grima, Monique Borg Inguanez, Jurgen Gerada, Pierre Ellul, Mario Vassallo, Neville Azzopardi, James Pocock, Alex Gatt |
|
| Transfused platelets enhance alloimmune responses to transfused KEL-expressing red blood cells in a murine model |
| David J. Madrid, Manjula Santhanakrishnan, Jingchun Liu, David R. Gibb, Dong Liu, Prabitha Natarajan, Daniel Beitler, Zhimin Shi, Chunyan Mo, Christopher A. Tormey, Seema R. Patel, Sean R. Stowell, Jeanne E. Hendrickson |
|
| Cost of Pathogen Reduction for platelets: reply to Cicchetti et al. Blood Transfus 2018; 16: 483-9 |
| Albert Farrugia |
|
| Comprehensive phenotypic and molecular investigation of RhD and RhCE variants in Moroccan blood donors |
| Houria El Housse, Mariam El Wafi, Zainab Ouabdelmoumene, Fatima Zarati, Rachida Alid, Nadia Nourichafi, Kamal Bouisk, Mohammed Benajiba, Claude Férec, Yann Fichou, Norddine Habti |
|
| Platelet cut-off for anticoagulant therapy in thrombocytopenic patients with blood cancer and venous thromboembolism: an expert consensus |
| Mariasanta Napolitano, Giorgia Saccullo, Marco Marietta, Monica Carpenedo, Giancarlo Castaman, Elisabetta Cerchiara, Antonio Chistolini, Laura Contino, Valerio De Stefano, Anna Falanga, Augusto B. Federici, Elena Rossi, Rita Santoro, Sergio Siragusa on behalf of the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) Working Party on Thrombosis and Haemostasis (see Appendix 1*) |
|
| Prevention and management of acute reactions to intravenous iron in surgical patients |
| Susana Gómez-Ramírez, Aryeh Shander, Donat R. Spahn, Michael Auerbach, Giancarlo M. Liumbruno, Stefania Vaglio, Manuel Muñoz |
|
| Identification of novel mutations in patients with fibrinogen disorders and genotype/phenotype correlations |
| Elena Chinni, Giovanni Tiscia, Giovanni Favuzzi, Filomena Cappucci, Giuseppe Malcangi, Rossana Bagna, Claudia Izzi, Domenica Rizzi, Valerio De Stefano, Elvira Grandone |
|
| Influence of apheresis collection device and container on the storage properties of platelets in 90% PAS-5/10% plasma |
| Stephen J. Wagner, Cheryl A. Hapip, Annette Turgeon, Lenora Abel, Nadine Kaelber |
|
| Molecular genetic analysis of weak ABO subgroups in the Chinese population reveals ten novel ABO subgroup alleles |
| Haobo Huang, Sha Jin, Xi Liu, Zhongying Wang, Qiong Lu, Liangfeng Fan, Wei Shen, Hang Lei, Chengrui Qian, Xuefeng Wang, Dong Xiang, Xiaohong Cai |
|
| Intravenous immunoglobulin replacement treatment reduces in vivo elastase secretion in patients with common variable immune disorders |
| Alessandro Prezzo, Filomena M. Cavaliere, Cinzia Milito, Caterina Bilotta, Metello Iacobini, Isabella Quinti |
|
| Experience with RHD*weak D type 4.0 in the USA |
| Connie M. Westhoff, Sandra Nance, Christine Lomas-Francis, Margaret Keller, Stella T. Chou |
|
| Predicting factors for liver iron overload at the first magnetic resonance in children with thalassaemia major |
| Maddalena Casale, Maria Marsella, Massimiliano Ammirabile, Anna Spasiano, Silvia Costantini, Patrizia Cinque, Paolo Ricchi, Aldo Filosa |
|
| Reversal of apixaban induced alterations in haemostasis by different coagulation factor concentrates in patients after hip or knee replacement surgery |
| Katrin Schmidt, Kerstin Krüger, Elisabeth Langer, Martin Schmutzler, Elke Johnen, Klaus D. Wernecke, Christian von Heymann, Mareike K. Körber |
|
| A proposal for a rational transfusion strategy in patients of European and North African descent with weak D type 4.0 and 4.1 phenotypes |
| Willy A. Flegel, Thierry Peyrard, Jacques Chiaroni, Christophe Tournamille, Déborah Jamet, France Pirenne |
|
| On the cost-utility of methylene blue-photoinactivated plasma versus quarantine plasma in Spain |
| Arturo Pereira, Julio del Río-Garma, José A. García-Erce |
|
| Red blood cell salvage analysis from clotted blood |
| Ethan K. Craig, Mark H. Yazer, Jonathan H. Waters |
|
| High resolution melting for F9 gene mutation analysis in patients with haemophilia B |
| Roberta Salviato, Donata Belvini, Paolo Radossi, Giuseppe Tagariello |
|
| A model-based cost-effectiveness analysis of Patient Blood Management |
| Adina Kleinerüschkamp, Patrick Meybohm, Niels Straub, Kai Zacharowski, Suma Choorapoikayil |
|
| ABO blood groups and psychiatric disorders: a Croatian study |
| Sandra Vuk Pisk, Tomislav Vuk, Ena Ivezic, Irena Jukic, Jasna Bingulac-Popovic, Igor Filipcic |
|
| Screening and identification of RhD antigen mimic epitopes from a phage display random peptide library for the serodiagnosis of haemolytic disease of the foetus and newborn |
| Jiao Wang, Jingjing Song, Shuimei Zhou, Yourong Fu, Jeffrey A. Bailey, Changxin Shen |
|
| SMIM1 polymorphisms in a donor population from Southeast Brazil and their correlation with VEL expression |
| Carine Prisco Arnoni, Tatiane A. de Paula Vendrame, Janaína Guilhem Muniz, Diana Gazito, Rosangela Duarte de Medeiros Person, Afonso J. Pereira Cortez, Flavia R. M. Latini, Lilian Castilho |
|
| Further comments on "High-titre inhibitors in previously untreated patients with severe haemophilia A receiving recombinant or plasma-derived factor VIII: a budget-impact analysis" |
| Andrea Messori, Flora Peyvandi, Sabrina Trippoli, Roberta Palla, Frits R. Rosendaal, Pier Mannuccio Mannucci |
|
| Reply to "High-titre inhibitors in previously untreated patients with severe haemophilia A receiving recombinant or plasma-derived factor VIII: a budget-impact analysis" by Messori et al. |
| Albert Farrugia, Megha Bansal |
|